Jove
Visualize
联系我们

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

<i>In vitro</i> antibacterial activity of gepotidacin in combination with other antimicrobial agents against <i>Neisseria gonorrhoeae</i> isolates.

Antimicrobial agents and chemotherapy·2026
Same author

Influence of different media and incubation times for determining the minimum inhibitory concentrations of gepotidacin, ciprofloxacin and ceftriaxone against Neisseria gonorrhoeae.

Diagnostic microbiology and infectious disease·2026
Same author

Creating a roadmap to fast-track human-centric non-animal methodologies via innovative funding mechanisms and strategic partnerships.

ALTEX·2026
Same author

Exploring the activity of a novel orally bioavailable β-lactam-β-lactamase inhibitor combination, ceftibuten-ledaborbactam, against Enterobacterales-carrying <i>bla</i><sub>OXA-48</sub>.

Microbiology spectrum·2025
Same author

Development of a rezafungin isolate verification panel and comparison of reference method to ThermoFisher Sensititre YeastOne panel MIC results.

Diagnostic microbiology and infectious disease·2025
Same author

Assessment of human exposures of cefepime-taniborbactam against cefepime-resistant Enterobacterales and <i>Pseudomonas aeruginosa</i> in a 7-day hollow fiber infection model.

Antimicrobial agents and chemotherapy·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Sep 10, 2025

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

29.1K

建立了Cefepime-taniborbactam的参考汁微稀释MIC方法.

Adam Belley1, Susan M Cusick1, Dan C Pevear1

  • 1Venatorx Pharmaceuticals Inc, Malvern, Pennsylvania, USA.

Journal of clinical microbiology
|August 19, 2025
PubMed
概括

开发并验证了一种新的参考方法来测试抗生素Cefepime-taniborbactam,该抗生素用于抗性格兰氏阴性感染. 这种可靠的方法确保了准确的敏感性测试,支持难以治疗的细菌感染的临床决策.

关键词:
伪omonas空气菌 伪omonas空气菌牛微稀释的方法碳烯质量质量问题这是一个很快的时间.它们是肠杆菌.参考方法 参考方法 参考方法易感性测试 易感性测试 易感性测试这就是Taniborbactam.

更多相关视频

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.5K
Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

33.2K

相关实验视频

Last Updated: Sep 10, 2025

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

29.1K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.5K
Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

33.2K

科学领域:

  • 微生物学 微生物学
  • 临床实验室科学 临床实验室科学
  • 抗微生物耐药性 抗微生物耐药性

背景情况:

  • 严重的格拉姆阴性细菌感染构成重大威胁,特别是那些对当前抗生素,如第三代类菌素和卡巴类药物耐药的细菌.
  • 试验中的β-乳酸/β-乳酸酶抑制剂组合,cefepime-taniborbactam,显示出治疗这些具有挑战性的感染的前景.
  • 标准化敏感性测试方法对于指导患者护理和确保新抗菌剂的有效使用至关重要.

研究的目的:

  • 建立和验证一个参考微稀释方法来确定cefepime-taniborbactam的最小抑制度 (MIC).
  • 确保该方法符合临床实验室标准研究所 (CLSI) 和国际标准组织 (ISO) 的指导方针.
  • 为了确定适当的质量控制 (QC) 参数和菌株,用于对cefepime-taniborbactam进行例行测试.

主要方法:

  • 针对cefepime-taniborbactam开发了一种参考微稀释MIC方法,其中taniborbactam的固定值为4μg/mL.
  • 进行了一项CLSI M23二级研究,涉及9个临床微生物学实验室.
  • 评估了*Escherichia coli*NCTCC 13353作为QC菌株的适用性,并测试了各种介质和测试参数的稳定性.

主要成果:

  • 确认*Escherichia coli*NCTCC 13353菌株适合进行常规的质量检查,并确定了非重叠的MIC范围,用于塞费皮姆和塞费皮姆-坦尼博巴克坦.
  • 在实验室间研究中,在获得的MIC结果和确定的QC范围之间观察到高一致性 (99.6%).
  • 该方法证明了稳定性,只有显著改变的注射位会影响QC范围以外的MIC值.

结论:

  • 开发的汁微稀释MIC参考方法用于cefepime-taniborbactam是强大的,可靠的,适合标准化的敏感性测试.
  • 这种经过验证的方法将通过提供Cefepime-taniborbactam的准确MIC数据来帮助告知患者护理.
  • 这些发现有助于解决抗生素耐药性感染的挑战,通过促进cefepime-taniborbactam的临床评估.